Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Orocam Transmucosal Oral Spray Patent Expiration

Orocam Transmucosal Oral Spray is a drug owned by ZOETIS INC. It is protected by 3 US drug patents filed from 2016 to 2030. Out of these, 1 patent is active and 2 patents have expired. Details of Orocam Transmucosal Oral Spray’s patents and their expiration are given below.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Patent Number Drug Patent Expiry Status
US6110486 12 Apr, 2016 Expired
US6969508 01 Oct, 2017 Expired
US8097614 13 May, 2030 Active

Exclusivity Information

Orocam Transmucosal Oral Spray holds 1 exclusivity out of which 1 has expired. Details of Orocam Transmucosal Oral Spray's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCI Nov 02, 2015

About Orocam Transmucosal Oral Spray

Orocam Transmucosal Oral Spray is a drug owned by ZOETIS INC. Orocam Transmucosal Oral Spray uses Meloxicam as the active ingredient.

Active Ingredient:

Orocam Transmucosal Oral Spray uses Meloxicam as the active ingredient. Check out other Drugs and Companies using Meloxicam ingredient.